Treatment of Metastatic Renal Cell Carcinoma: How Reliable are Small Non-Randomised Clinical Trials? Concerning Mross et al.: Onkologie 1999;22:412–415.

Publisher： Karger

E-ISSN： 2296-5262|22|6|520-520

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.22, Iss.6, 2000-01, pp. : 520-520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Micrometastases and Microinvolvement in Esophageal Carcinoma. Concerning Feith et al.: Clinical relevance of lymph node micrometastases in esophageal carcinoma. Onkologie 2000;23:330–333

By  

Oncology Research and Treatment, Vol. 23, Iss. 5, 2000-11 ,pp. : 478-479

Karger

Access to resources Recommend Favorite

Rechnitzer S, et al.: Pretreatment Prognostic Factors for Survival in Non-Small-Cell Lung Cancer: A Multivariate Analysis of 229 Patients. Onkologie 1998;21:204–209. Is there a Need for New Prognostic Factors in Non-Small-Cell Lung Cancer?

By  

Oncology Research and Treatment, Vol. 21, Iss. 3, 1998-07 ,pp. : 248-248

Karger

Access to resources Recommend Favorite

Clinical and Safety Profile of High-Dose Interleukin-2 Treatment in Elderly Patients with Metastatic Melanoma and Renal Cell Carcinoma

By  

Oncology, Vol. 84, Iss. 2, 2012-12 ,pp. : 123-126

Karger

Access to resources Recommend Favorite

Treatment Algorithm for Metastatic Renal Cell Carcinoma - Recommendations Based on Evidence and Clinical Practice

By  

Oncology Research and Treatment, Vol. 37, Iss. 3, 2014-02 ,pp. : 136-141

Karger

Access to resources Recommend Favorite

Clinical experience with sunitinib dose escalation in metastatic renal cell carcinoma

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 3, 2015-09 ,pp. : e1-e5

John Wiley & Sons Inc

Access to resources Recommend Favorite